About Geneombio Technologies Private Limited
Data last updated:
Geneombio Technologies Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Resilient Cosme-Ceuticals Private Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 06 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2005PTC020977. Its GSTIN is 27AACCG4202H1Z0 (Maharashtra).
The company has an authorised share capital of ₹2.85 Cr and a paid-up capital of ₹2.8 Cr. It was formerly known as Geneom Biotech Private Limited. It is led by directors Yashwant Govind Chavan and Sachin Sharad Purohit.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.07 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹37.81 Lakh (net margin 6.2%) and EBITDA of ₹1.11 Cr (EBITDA margin 18.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 13% over five years.
The company has about 29 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Geneombio Technologies. As per MCA filings, the company has open charges of ₹1.87 Cr and satisfied charges of ₹3.6 Cr on record. The company has 1 deal on record (1 acquisition); the latest was in August 2011. Its 10 peer companies in the Healthcare industry (Diagnostics and Pathology Labs) are compared by revenue, 5 larger and 5 smaller; the largest is Doon Mri Private Limited with revenue of ₹6.14 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website geneombiotechnologies.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressOffice No. 302 Third Floor Lalani Quantum, Survey No. 322/A 323/1A 324/1A, Pune, Maharashtra, India – 411021
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Geneombio Technologies Private Limited
The main business activities of Geneombio Technologies are hospital and medical care, professional, scientific and technical and trade. In detail, this covers medical and dental practice, nursing, pathology, blood bank services, etc., other professional, scientific and technical activities and wholesale trading. 3 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Geneombio Technologies Private Limited FY 2025 filings available
Geneombio Technologies Private Limited reported revenue of ₹6.07 Cr (up 35% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Geneombio Technologies Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 35% growth in the latest year. EBITDA rose 342% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Geneombio Technologies Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.11 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹37.81 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Geneombio Technologies Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Geneombio Technologies are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Geneombio Technologies Private Limited
Geneombio Technologies Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Doon Mri Private Limited | ₹6.14 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Sriramnarayan Industries Private Limited | ₹6.13 Cr (FY 2025) | •••• | •••• | 41.0% | •••• | Ramgarah, Jharkhand, India |
| Proficient Medicare Private Limited | ₹6.12 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Naipukur Rajarhat, West Bengal, India |
| Jaipur Nuclear & Imaging Center Private Limited | ₹6.11 Cr (FY 2024) | •••• | •••• | 65.0% | •••• | Jaipur, Rajasthan, India |
| SDS Healthcare and Imaging Private Limited | ₹6.09 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Noida, Uttar Pradesh, India |
| Geneombio Technologies Private Limited this company | ₹6.07 Cr (FY 2024) | •••• | •••• | 35.0% | •••• | Pune, Maharashtra, India |
| Lab One Metropolis Healthcare Services Private Limited | ₹6.06 Cr (FY 2021) | •••• | •••• | -24.0% | •••• | Mumbai, Maharashtra, India |
| Maruti Healthcare Private Limited | ₹6.06 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Tiruvallur, Tamil Nadu, India |
| E.M.L. Health Care Private Limited | ₹6.03 Cr (FY 2024) | •••• | •••• | -9.0% | •••• | Bhopal, Madhya Pradesh, India |
| Indian Mri Diagnostic & Research Limited | ₹6.02 Cr (FY 2024) | •••• | •••• | -3.0% | •••• | Tamil Nadu, India |
| Aja Radiology Imaging and Medical Care Private Limited | ₹6.02 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Geneombio Technologies by revenue in the Healthcare industry (Diagnostics and Pathology Labs), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Geneombio Technologies Private Limited
Geneombio Technologies Private Limited is audited by S.D.DALE & COMPANY for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.D.DALE & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Geneombio Technologies Private Limited
Geneombio Technologies has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Yashwant Govind Chavan Also directs: Precibio Lifesciences LLP | Director | 01 Feb 2021 | 5 Years 8 Months | Current |
| Sachin Sharad Purohit Also directs: Precibio Lifesciences LLP, Panakos Food and Beverages Private Limited, Hygge Brew Private Limited and 1 more | Director | 06 Jul 2005 | 21 Years 3 Months | Current |
Ownership and Shareholding of Geneombio Technologies Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Geneombio Technologies Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2018 | Yes Bank Limited | ₹1.87 Cr | Open |
| 26 Jun 2013 | Canara Bank | ₹50 Lakh | Satisfied |
| 17 Jun 2006 | The Suvarna Sahakari Bank Ltd. | ₹30 Lakh | Satisfied |
| 29 Aug 2005 | The Suvarna Sahakari Bank Ltd. | ₹2.8 Cr | Satisfied |
Total charge records: 4 View all charges
Deals & Funding of Geneombio Technologies Private Limited
Geneombio Technologies Private Limited has 1 deal on record (1 acquisition); the latest was in August 2011.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2011 | Acquisition | ₹31.4 Lakh | Buyer: Innoventive Venture Limited |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Geneombio Technologies Private Limited
Geneombio Technologies operates one associated brand: Geneombio Technologies. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Molecular diagnostic, contract research, and animal genetic services are provided. | geneombiotechnologies.com |
Employees and EPFO Compliance at Geneombio Technologies Private Limited
Geneombio Technologies Private Limited has a workforce of 29 employees as of Apr 10, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
News related to Geneombio Technologies Private Limited
Recent Activity on Geneombio Technologies Private Limited
Geneombio Technologies Private Limited has 12 board changes on record since 2005: 2 appointments and 10 cessations. The latest: Anagha Sachin Purohit ceased to be Director on 25 Jul 2022.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Geneombio Technologies Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Geneombio Technologies Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Geneombio Technologies Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Geneombio Technologies Private Limited
Geneombio Technologies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCG4202H1Z0 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Geneombio Technologies Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geneombio Technologies Private Limited
Geneombio Technologies is an active private limited company based in Pune, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 06 July 2005 (21+ years old) and is registered under CIN U24239PN2005PTC020977.
Geneombio Technologies reported revenue of ₹6.07 Cr for FY 2024 (up 35% YoY).
Geneombio Technologies has 2 current directors:
- Yashwant Govind Chavan - Director
- Sachin Sharad Purohit - Director
Geneombio Technologies reported a net profit of ₹37.81 Lakh (net margin 6.2%) and EBITDA of ₹1.11 Cr (EBITDA margin 18.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Geneombio Technologies is 12% over three years and 13% over five years. In the latest year (FY 2024) revenue rose 35%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Geneombio Technologies is 27AACCG4202H1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Geneombio Technologies is U24239PN2005PTC020977. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Geneombio Technologies was incorporated on 06 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Pune.
Geneombio Technologies has 1 deal on record (1 acquisition); the latest was in August 2011.
The peers of Geneombio Technologies by revenue are Doon Mri Private Limited, Sriramnarayan Industries Private Limited, Proficient Medicare Private Limited, Jaipur Nuclear & Imaging Center Private Limited, SDS Healthcare and Imaging Private Limited and 5 more, all in the Healthcare industry (Diagnostics and Pathology Labs).
Anagha Sachin Purohit ceased to be Director on 25 Jul 2022. Amol Dasharath Raut ceased to be Additional Director on 29 Nov 2021. Yashwant Govind Chavan ceased to be Additional Director on 29 Nov 2021. Geneombio Technologies has 12 board changes on record in total.